Pascal Richette

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Patients with inflammatory rheumatisms, such as rheumatoid arthritis, are more prone to develop skin cancers than the general population, with an additional increased incidence when receiving TNF blockers. There is therefore a need that physicians treating patients affected with inflammatory rheumatisms with TNF blockers recognize malignant skin lesions,(More)
  • 1